For the quarter ending 2025-09-30, CMPOW had $49,901K increase in cash & cash equivalents over the period. -$8,893K in free cash flow.
| Cash Flow | 2025-09-30 |
|---|---|
| Net loss | -179,329 |
| Depreciation and amortization | 1,623 |
| Stock-based compensation expense | 4,223 |
| Earnings in equity method investment | 93,390 |
| Cash receipts from holdings | 21,659 |
| Amortization of deferred financing costs | 74 |
| Loss on extinguishment of debt | 0 |
| Revaluation of earnout consideration liability | -57,101 |
| Revaluation of warrant liability | 152,782 |
| Change in fair value of derivative liability | 0 |
| Non-cash operating lease expense | 405 |
| Deferred tax benefit | -1,837 |
| Accounts receivable | -2,063 |
| Inventories | 5,195 |
| Prepaid expenses and other assets | 3,256 |
| Accounts payable | -29 |
| Accrued expenses | 38,230 |
| Lease liabilities | -369 |
| Other liabilities | -3,648 |
| Net cash (used in ) provided by operating activities | -8,893 |
| Purchase of property and equipment | 0 |
| Holdings cash deconsolidated as a result of the management agreement | 50,303 |
| Resolute holdings cash deconsolidated as a result of the spin-off | 10,000 |
| Capitalized software expenditures | 387 |
| Net cash used in investing activities | -60,690 |
| Proceeds from employee stock purchase plan and exercise of options | 121 |
| Payments for taxes related to net share settlement of equity awards and earnout liability | 18,011 |
| Payment of term loan | 0 |
| Purchase of treasury shares | 12,247 |
| Deferred finance costs related to debt modification | 0 |
| Payment of tax receivable agreement liability | 4,735 |
| Distributions to non-controlling members | 0 |
| Special distribution to non-controlling members | 0 |
| Dividend to class a shareholders | 0 |
| Proceeds from the exercise of warrants | 154,356 |
| Net cash provided by (used in) financing activities | 119,484 |
| Net increase in cash and cash equivalents | 49,901 |
| Cash and cash equivalents at beginning of period | 77,461 |
| Cash and cash equivalents at end of period | 127,362 |
CompoSecure, Inc. (CMPOW)
CompoSecure, Inc. (CMPOW)